Article RDF
pages:- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- more...
- Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment
- Phaeohyphomycosis Infections in Solid Organ Transplant Recipients - The Largest Single Institution Experience
- Pharmaco-Immunomodulatory Therapy in COVID-19
- Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice
- Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review
- Phase 2 open-label, dose-finding study of intravenous ganaxolone for the treatment of refractory status epilepticus
- Phase 2, randomized, double-blind, placebo-controlled multi- center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia
- PHASE I CANCER CLINICAL TRIAL FOR 4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE (DM-CHOC-PEN)
- Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia
- Phase Ib clinical study of CBP501, cisplatin and nivolumab administered every 3 weeks in patients with advanced refractory tumors. Dose escalation cohort
- Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every three weeks in patients with advanced refractory tumors: Efficacy in dose-escalation and expansion cohorts.
- Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma
- Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS.
- Phase II clinical trial: Safety and efficacy study of tocilizumab (Toci) in combination with ipilimumab (Ipi) 3mg/kg plus nivolumab (Nivo) 1mg/kg in patients (pts) with metastatic melanoma (MM)
- Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma
- Phenotype and mutation expansion of the PTPN23 associated disorder characterized by neurodevelopmental delay and structural brain abnormalities
- PHENOTYPE AND OUTCOMES OF ACUTE KIDNEY INJURY ASSOCIATED WITH COVID-19 (Withdrawn Publication. See vol. 69, pg. 947, 2021) (Withdrawn Publication. See vol. 69, pg. 947, 2021)
- Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations
- Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants
- PHEOCHROMOCYTOMA OF THE ORGAN OF ZUCKERLANDL
- Phoma Infections: Classification, Potential Food Sources, and Their Clinical Impact
- Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments
- Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status
- Physical Activity and Cardiorespiratory Fitness as Modulators of Health Outcomes: A Compelling Research-Based Case Presented to the Medical Community
- Physical activity and fitness vs adiposity and weight loss for the prevention of cardiovascular disease and cancer mortality
- Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults
- Physical Activity Promotion in the Health Care System
- Physical Activity to Reduce Subclinical Myocardial Injury Associated Heart Failure in Blacks
- Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults
- Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults